"/> Novus Biologicals™ Peptide bloquant d’anticorps DR… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps DRAK2

Réf. : BL-RE-081447Réf. fabricant : 18249135 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
9262
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76885. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the carboxy terminus of human DRAK2.

Points forts

Source

Synthetic

(Accession #: AB011421) The DRAK2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-081447
Réf. fabricant18249135
Gene ID (Entrez)9262
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76885. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneDAP kinase-related apoptosis-inducing protein kinase 2, DRAK2death-associated protein kinase-related 2, EC 2.7.11, EC 2.7.11.1, serine/threonine kinase 17 b, serine/threonine kinase 17 b (apoptosis-inducing), serine/threonine-protein kinase 17 B
Symbole de gène(s)STK17B
Type de produitDRAK2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the carboxy terminus of human DRAK2
Une question, une configuration particulière ?
Contactez-nous pour un devis.